There have been numerous patient reports (as well as Getinger's claim on the Asco CC) that 113 is clearly better tolerated than LDK. I believe that will be a clear differentiator in the end.
IMO little to no value has been assigned to 113 in Ariad's pps at this point.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.